Arrhythmia in COVID-19

SN Compr Clin Med. 2020;2(9):1430-1435. doi: 10.1007/s42399-020-00454-2. Epub 2020 Aug 14.

Abstract

The current outbreak of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) also known as coronavirus disease 2019 (COVID-19) has quickly progressed to a global pandemic. There are well-documented cardiac complications of COVID-19 in patients with and without prior cardiovascular disease. The cardiac complications include myocarditis, heart failure, and acute coronary syndrome resulting from coronary artery thrombosis or SARS-CoV-2-related plaque ruptures. There is growing evidence showing that arrhythmias are also one of the major complications. Myocardial inflammation caused by viral infection leads to electrophysiological and structural remodeling as a possible mechanism for arrhythmia. This could also be the mechanism through which SARS-CoV-2 leads to different arrhythmias. In this review article, we discuss arrhythmia manifestations in COVID-19.

Keywords: Arrhythmias; Atrial fibrillation; Coronavirus disease 2019; Middle east respiratory syndrome; QT prolongation; Severe acute respiratory syndrome; Sinus bradycardia; Sinus tachycardia; Torsade de pointes; Ventricular arrhythmias; Ventricular fibrillation; Ventricular tachycardia; Viral infection.

Publication types

  • Review